Class 4 Medicines Defect Notification: Ipca Laboratories UK Limited, Various Products, EL(25)A/42

2025-08-26T13:00:26+01:00

Ipca Laboratories UK Ltd has informed the MHRA that the Patient Information Leaflet (PIL) in the products listed in this notification do not contain all the required safety information.